GlassScriptPhysician profile
Grant D Taylor
NPI 1427013044
$3,898.82
in general payments reported to CMS, 2019-2025
36 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $159 · 2021: $870 · 2022: $514 · 2023: $47.49 · 2024: $359 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $975.19 | 2019-2025 | General - Female Sui, Lumenis Pulse 120h, Tria Firm |
| Astellas Pharma US INC | $558.25 | 2019-2022 | |
| Janssen Biotech, INC. | $334.97 | 2019-2024 | Erleada |
| Axonics, INC. | $177.70 | 2020-2024 | Bulkamid, Axonics |
| Teleflex LLC | $161.46 | 2021-2025 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $148.09 | 2023-2025 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $123.33 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $116.97 | 2024-2025 | Gemtesa |
| Abbvie INC. | $115.08 | 2019-2025 | |
| Pfizer INC. | $96.51 | 2019-2020 | |
| Tolmar, INC. | $91.16 | 2024-2025 | Jatenzo, Eligard |
| Rochester Medical Corporation | $75.94 | 2022 | |
| Myovant Sciences INC. | $74.24 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $73.47 | 2022 | |
| Medtronic, INC. | $71.09 | 2021-2025 | Roticulator |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $68.03 | 2019-2020 | |
| Antares Pharma, INC. | $61.19 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $50.78 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $47.93 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Agiliti Surgical, INC. | $46.86 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Blue Earth Diagnostics | $46.63 | 2021 | |
| Procept Biorobotics Corporation | $44.85 | 2024-2025 | Aquabeam System |
| Intuitive Surgical, INC. | $37.95 | 2019 | |
| Smith+Nephew, INC. | $35.13 | 2019 | |
| Ambu INC. | $32.27 | 2020-2025 | |
| Photocure INC | $31.48 | 2021 | |
| Endo Pharmaceuticals INC. | $30.21 | 2019 | |
| Calyxo, INC. | $27.89 | 2025 | Cvac Aspiration System |
| Zyla Life Sciences, INC. | $24.68 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $23.53 | 2022 | |
| Travere Therapeutics, INC. | $18.13 | 2019 | |
| Urovant Sciences INC | $16.76 | 2022 | |
| Merck Sharp & Dohme LLC | $16.13 | 2021 | |
| Ethicon US, LLC | $16.11 | 2025 | Vistaseal, Surgicel Nu-Knit |
| Coloplast Corp | $14.77 | 2020 | |
| Abc Home Medical Supply, INC. | $14.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.